```html

Quaker Disease (Ankylosing Spondylitis) – A Complete Patient Guide

Overview

Ankylosing spondylitis (AS), sometimes called Quaker disease because of its historic prevalence among the Religious Society of Friends (Quakers) in England, is a chronic inflammatory arthritis that primarily affects the spine and sacroiliac (SI) joints. Over time, the inflammation can cause new bone formation, leading to the fusion of vertebrae—a condition known as “ankylosis.” This fusion reduces flexibility and can cause a forward‑bent posture.

Who it affects

• Most commonly diagnosed in men (≈ 2–3 times more often than women).
• Typical age of onset: late teens to early 30s, though symptoms can appear before age 10 or after age 45.
• Higher prevalence in individuals of Northern European ancestry.

Prevalence

• Global prevalence is estimated at 0.1‑0.5 % of the population (≈ 1‑5 cases per 1,000 people) [1] WHO, 2022.
• In the United States, about 1.3 million adults live with AS, representing roughly 0.4 % of the adult population [2] CDC, 2023.

Symptoms

Symptoms develop gradually and can vary widely between individuals. Early recognition is key to preventing permanent spinal damage.

Back and spinal pain

• Location: Low back and buttocks, often worse at night or after periods of inactivity.
• Pattern: Improves with exercise and worsens with rest; “stiff morning” is classic.
• Radiation: Pain may radiate to the hips, thighs, or down the legs (sciatica‑like).

Sacroiliac joint involvement

• Pain and tenderness over the posterior iliac crest.
• Reduced ability to stand on one leg or cross legs without discomfort.

Peripheral arthritis

• Swelling and pain in shoulders, hips, knees, or ankles.
• Enthesitis – inflammation where tendons or ligaments attach to bone (e.g., heel pain from Achilles tendon insertion).

Systemic features

• Fatigue and low‑grade fever.
• Uveitis (inflammation of the eye) in up to 40 % of patients – causes redness, pain, photophobia.
• Inflammatory bowel disease (Crohn’s or ulcerative colitis) in 5‑10 % of cases.

Postural changes

• Gradual loss of spinal flexibility, leading to a “stooped” or “chin‑on‑chest” posture.
• Reduced chest expansion, which can affect breathing during vigorous activity.

Causes and Risk Factors

Genetic predisposition

• Over 90 % of patients carry the HLA‑B27 gene variant. Not everyone with HLA‑B27 develops AS, but the risk is markedly increased [3] NIH, 2021.
• Other genes (ERAP1, IL23R) modify risk but have smaller effects.

Environmental triggers

• Gut microbiome alterations – studies suggest bacterial dysbiosis may “activate” immune pathways in genetically susceptible individuals.
• Infections (especially gastrointestinal or genitourinary) have been implicated as possible triggers, though causality is not definitive.

Demographic risk factors

• Male sex.
• Age 15‑35 years at symptom onset.
• Family history of AS or other HLA‑B27‑associated diseases (e.g., reactive arthritis, uveitis).
• Ethnicity: Higher prevalence among people of Northern European descent; lower prevalence in Asian and African populations.

Diagnosis

Diagnosis relies on a combination of clinical history, physical examination, imaging, and laboratory tests.

Clinical criteria

• Modified New York Criteria (1984) – requires chronic low‑back pain >3 months, onset before age 45, sacroiliitis on imaging, and at least one of the following: limited lumbar motion, limitation of chest expansion, or positive Schober test.

Imaging studies

• Plain X‑ray: Detects sacroiliitis and later-stage spinal fusion; may be normal in early disease.
• MRI (magnetic resonance imaging): Gold standard for early detection; shows bone marrow edema and active inflammation before structural changes appear.
• CT scan: Provides detailed bone architecture, useful when X‑ray findings are equivocal.

Laboratory tests

• HLA‑B27 typing – supportive but not diagnostic.
• Elevated acute‑phase reactants (ESR, CRP) indicate active inflammation but are not specific.
• Complete blood count and metabolic panel to rule out infection or medication side effects.

Other evaluations

• Ophthalmology exam if eye symptoms are present (uveitis screening).
• Gastroenterology referral when inflammatory bowel disease is suspected.

Treatment Options

Pharmacologic therapy

1. Non‑steroidal anti‑inflammatory drugs (NSAIDs) – First‑line for pain and stiffness. Examples: naproxen, ibuprofen, celecoxib. Continuous use may slow radiographic progression in some patients.
2. Biologic disease‑modifying antirheumatic drugs (bDMARDs)
   • TNF‑α inhibitors (e.g., etanercept, adalimumab, infliximab, golimumab, certolizumab). Reduce inflammation and improve function in ~60‑70 % of patients.
   • IL‑17 inhibitors (secukinumab, ixekizumab). Useful for patients who do not respond to or cannot tolerate TNF blockers.
3. Targeted synthetic DMARDs (tsDMARDs) – Janus kinase (JAK) inhibitors such as upadacitinib have shown efficacy but carry a warning for thrombosis and infection.
4. Conventional DMARDs (sulfasalazine, methotrexate) – Limited benefit for axial disease but may help peripheral joint involvement.
5. Corticosteroids – Short courses for acute flares; long‑term systemic use is discouraged due to side‑effects.

Physical therapy and rehabilitative measures

• Daily stretching and strengthening exercises to preserve spinal mobility.
• Postural training (e.g., thoracic extension exercises) to counteract forward flexion.
• Breathing exercises to improve chest expansion.

Surgical interventions

• Joint replacement (hip or knee) when severe arthropathy causes disabling pain.
• Spinal osteotomy or corrective surgery – Reserved for advanced cases with severe deformity; performed by experienced orthopedic spine surgeons.

Lifestyle and adjunctive therapies

• Smoking cessation – Smoking doubles the risk of radiographic progression [4] Cleveland Clinic, 2020.
• Weight management – Reduces mechanical stress on joints.
• Regular aerobic activity (walking, swimming, cycling) – Improves cardiovascular health and reduces stiffness.
• Adequate sleep and stress‑reduction techniques (mindfulness, yoga) – Helpful for pain perception.

Living with Quaker disease (ankylosing spondylitis)

Daily management tips

• Morning routine: Perform gentle spinal flexion‑extension stretches (e.g., cat‑cow, seated thoracic rotations) before getting out of bed.
• Exercise schedule: Aim for at least 150 minutes of moderate aerobic activity per week plus 2–3 sessions of targeted stretching/strengthening.
• Ergonomic modifications: Use a supportive chair with lumbar roll, keep computer monitor at eye level, and take micro‑breaks every 30 minutes to stand and move.
• Medication adherence: Keep a medication log; set alarms for biologic infusion or injection appointments.
• Eye health: If you develop eye redness, pain, or light sensitivity, see an eye doctor promptly—uveitis can cause permanent visual loss if untreated.
• Travel considerations: Pack a travel‑size NSAID, bring a copy of medication list, and request aisle seats to allow easy standing/stretching.

Support resources

• National Ankylosing Spondylitis Society (NASS) – patient education, support groups.
• Arthritis Foundation – online community and exercise videos tailored to axial spondyloarthritis.
• Psychological counseling – chronic pain can impact mental health; cognitive‑behavioral therapy (CBT) has demonstrated benefits.

Prevention

Because AS has a strong genetic component, primary prevention is limited. However, several measures can reduce the likelihood of severe disease or delay progression:

• Avoid smoking: Quit before symptom onset; secondhand smoke also increases risk.
• Maintain a healthy gut: A balanced diet rich in fiber, fermented foods, and possibly probiotic supplementation may support a favorable microbiome—research is ongoing.
• Early detection: Relatives of an AS patient who are HLA‑B27 positive should seek medical evaluation if back pain develops before age 40.
• Prompt treatment: Starting NSAIDs or biologics early in the disease course improves long‑term function and may limit irreversible fusion.

Complications

If left untreated or poorly controlled, ankylosing spondylitis can lead to serious health issues:

• Spinal fusion (ankylosis): Rigid spine increases risk of fractures, especially from low‑impact falls.
• Reduced chest expansion: Can cause restrictive lung disease and decreased exercise tolerance.
• Uveitis: Recurrent inflammation may lead to cataracts, glaucoma, or vision loss.
• Inflammatory bowel disease: Requires separate gastroenterology management.
• Cardiovascular disease: Chronic systemic inflammation modestly raises risk of atherosclerosis and heart attack.
• osteoporosis: Inflammation and reduced mobility predispose to bone loss, further increasing fracture risk.

When to Seek Emergency Care

---

References

1. World Health Organization. “Global Health Estimates – Ankylosing Spondylitis Prevalence.” 2022.
2. Centers for Disease Control and Prevention. “Arthritis Data & Statistics – Ankylosing Spondylitis.” 2023.
3. National Institutes of Health. “HLA‑B27 and Ankylosing Spondylitis.” NIH Genetics Review, 2021.
4. Cleveland Clinic. “Smoking and Spondyloarthritis – Impact on Disease Progression.” 2020.
5. Mayo Clinic. “Ankylosing Spondylitis – Symptoms, Causes, and Treatment.” Updated 2024.
6. American College of Rheumatology. “2022 Guideline for the Treatment of Ankylosing Spondylitis.” Arthritis Care & Research, 2022.

```